Pyxis Oncology
(NASDAQ) PYXS
Pyxis Oncology Financials at a Glance
Market Cap
$169.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$13.86M
Net Income (TTM)
-$81.74M
EPS (TTM)
-$1.30
P/E Ratio
-2.05
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$2.67
Volume
853,134
Open
$2.64
Price
$2.67
Volume
853,134
Open
$2.64
Previous Close
$2.67
Daily Range
$2.40 - $2.69
52-Week Range
$0.97 - $5.55
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$2.67
Volume
853,134
Open
$2.64
Previous Close
$2.67
Daily Range
$2.40 - $2.69
52-Week Range
$0.97 - $5.55
Estimated Earnings Date
Aug 13, 2026
PYXS News
PYXS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pyxis Oncology
Industry
Biotechnology
Sector
Health CareEmployees
56
CEO
Thomas Civik, MBA
Website
www.pyxisoncology.comHeadquarters
Boston, MA 02140, US
PYXS Financials
Key Financial Metrics (TTM)
Gross Margin
99.81%
Operating Margin
-619.61%
Net Income Margin
-589.80%
Return on Equity
-135.60%
Return on Capital
-117.12%
Return on Assets
-127.12%
Earnings Yield
-48.78%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$169.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
63.36M
Volume
853.13K
Avg. Volume
837.76K
Financials (TTM)
Gross Profit
$13.83M
Operating Income
-$85.87M
EBITDA
-$75.93M
Operating Cash Flow
-$66.97M
Capital Expenditure
-$9.00K
Free Cash Flow
-$66.98M
Cash & ST Invst.
$42.49M
Total Debt
$18.26M
Pyxis Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$459.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$169.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$3.02M
N/A
Employees
56
N/A
Net Income
-$23.27M
-10.0%
EBITDA
-$22.81M
-10.7%
Quarterly Fundamentals
Total Cash
$42.49M
-59.7%
Total Debt
$18.26M
-8.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$16.50M
-10.0%
Short Term Debt
$1.76M
+16.5%
Return on Assets
-1.27%
N/A
Return on Invested Capital
-1.80%
N/A
Free Cash Flow
-$26.00M
-15.4%
Operating Cash Flow
-$26.00M
-15.4%